Biomedical Perspectives on Alcohol Dependence: Genetic, Imaging and Biomarker Identification Studies
Biomedical Perspectives in Alcohol Dependence: Genetics, Imaging, and Marker Identification Studies
Biomedical Approach to Alcohol Dependence; Studies on Genetics, Imaging, Marker Identification
Dr. Arzu DALMIŞa, Dr. Neşe KOÇUKa, Dr. Yıldız AKVARDARa
aDepartment of Psychiatry, Dokuz Eylul University Faculty of Medicine, Izmir
Correspondence: Dr. Yıldız AKVARDAR
Address: Dokuz Eylul University Faculty of Medicine, Department of Psychiatry, Izmir, Turkey
E-mail: [email protected]
Abstract
Alcohol dependence can be considered a disorder influenced by multiple genes (polygenic), reflecting various characteristics and resulting from both genetic and environmental factors (multifactorial). The negative effects of alcohol on the brain generally manifest as volume loss in white and gray matter and enlargement of the ventricles. Considering the memory-impairing effects of ethanol, the hippocampus has become a focal point in research. Biochemical markers used as auxiliary tools in diagnosing alcohol use disorders are categorized into state markers and trait markers. Over the past 30 years, significant advances have been made in understanding the effects of alcohol, as well as in the etiology, diagnosis, and treatment of alcohol use disorders.
Keywords: Alcohol abuse, genetics, magnetic resonance imaging, biochemical markers
Abstract
Alcohol dependence might best be viewed as a disorder influenced by multiple genes (polygenic), reflecting multiple characteristics and involving both genetic and environmental causes (multifactorial). The negative effects of alcohol on the brain include loss of white and gray matter volume and ventricular enlargement. Since ethanol impairs memory, the hippocampus is the most frequently studied region. Biochemical markers that assist in diagnosing alcohol use disorders are divided into state markers and trait markers. Over the past three decades, significant progress has been made in understanding the effects of alcohol exposure, as well as the etiology, diagnosis, and treatment of alcohol use disorders.
Keywords: Alcohol abuse, genetics, magnetic resonance imaging, biochemical markers
GENETIC STUDIES IN ALCOHOL DEPENDENCE
Since the 1970s, family, adoption, and twin studies—supported by molecular genetic techniques—have provided strong evidence for the heritable aspects of alcohol dependence. Based on observations that children of alcohol-dependent parents are at increased risk of developing alcohol dependence, it has been suggested that the disorder is inherited. In 1979, Cotton reviewed 39 family studies conducted over 40 years, involving 6,251 alcohol-dependent and 4,083 non-dependent probands, and found that one in three alcohol-dependent individuals had at least one alcohol-dependent parent. Furthermore, the incidence of alcohol dependence among relatives of non-dependent individuals was significantly lower than among relatives of alcohol-dependent individuals.
Twin studies investigate heritability by comparing concordance rates between monozygotic (MZ) and dizygotic (DZ) twins. Kendler et al., in a large-scale study of female twin pairs, found significantly higher concordance rates in MZ twins compared to DZ twins. Studies conducted in Australia also found high concordance rates for alcohol use during adolescence and early onset of problematic drinking. The influence of genetic and environmental factors varies during adolescence; at ages 15–16, genetic and environmental contributions are approximately 34% and 58%, respectively, while after age 17, these rates shift to 43% and 37%. Adoption studies have been used to distinguish genetic from environmental influences. A Danish study found that 18% of adopted males with alcohol-dependent biological parents developed alcohol dependence, compared to 5% of those without such a background.
Observations that dependence is transmitted across generations have directed attention to identifying responsible genes. Molecular genetic studies aim to identify candidate genes influencing psychiatric phenotypes and to understand dysfunctional gene mechanisms. Neurotransmitter genes are key candidates in studying behavioral disorders. Studies have examined genes related to glutamate, serotonin, MAO-A, and opioid receptors, but generally no consistent association with alcohol dependence has been established.
Because dopamine plays a central role in the brain’s reward system, dopamine receptor genes have been a primary focus. Dopaminergic and opioidergic pathways mediate natural reward processes such as eating and reproduction, while substances like alcohol stimulate similar pathways artificially. Variations in neurotransmitter systems—including dopamine, serotonin, norepinephrine, GABA, opioids, and cannabinoids—may lead to “Reward Deficiency Syndrome.” Among dopamine receptor genes, DRD2 has been the most extensively studied. Research over the past decade suggests that the DRD2 TaqI A allele is associated with alcohol and substance dependence, smoking, obesity, compulsive gambling, and certain personality traits.
The DRD2 TaqI A1 allele has been found more frequently in alcohol-dependent individuals and appears to correlate with severity. This allele is associated with reduced dopaminergic activity in the central nervous system, potentially increasing the tendency to seek rewarding stimuli such as alcohol.
Volkow et al. demonstrated that reduced dopamine receptor density in the striatum of alcohol-dependent individuals may contribute to increased reward-seeking behavior. Despite some studies confirming associations between DRD2 polymorphisms and alcohol dependence, others have not, suggesting that alcohol dependence is influenced by multiple genes, ethnic variability, and environmental factors.
Research also suggests that personality traits may have genetic underpinnings. Associations have been found between dopamine receptor genes (DRD2, DRD4) and traits such as novelty seeking and harm avoidance. Although studies in alcohol-dependent populations are limited, findings indicate a potential link between DRD2 variants and anxiety-related traits, suggesting that anxious individuals may be more vulnerable to alcohol dependence.
IMAGING STUDIES
Heavy alcohol consumption adversely affects both physical and mental health. Repeated high-dose alcohol intake impacts nearly all organ systems, particularly the central nervous system. Alcohol’s neurotoxic effects result in structural brain changes accompanied by cognitive, emotional, and behavioral alterations.
These effects generally include loss of white and gray matter volume and ventricular enlargement, especially in frontal lobes, temporal regions, subcortical structures, and the cerebellum. Alcohol affects the brain both directly and indirectly through metabolic byproducts, nutritional deficiencies (e.g., vitamin B1 deficiency), and liver disease. Additional comorbid conditions such as cardiovascular disease, trauma, and psychiatric disorders may also contribute to brain changes.
Modern research highlights neuroinflammation as a key mechanism underlying alcohol-related neuropathology. Neurodegeneration, rather than simple atrophy, appears to play a central role. Experimental models, such as binge ethanol exposure in animals, have demonstrated neuronal death and impaired neurogenesis, particularly in the hippocampus.
Magnetic resonance imaging (MRI) is a valuable tool for assessing alcohol-related brain damage. Studies have identified widespread abnormalities in both cortical and subcortical regions, including reduced brain volume and increased cerebrospinal fluid. The hippocampus, critical for memory and emotion, is particularly affected.
BIOCHEMICAL MARKERS IN DIAGNOSIS OF ALCOHOL USE DISORDERS
Biochemical markers used in diagnosing alcohol use disorders are categorized as state markers and trait markers. State markers (e.g., GGT, MCV, CDT) indicate current or recent alcohol use, while trait markers reflect long-term susceptibility. Genetic markers fall into the latter category.
Gamma-glutamyl transferase (GGT) is the most commonly used marker due to its accessibility and low cost, although its specificity is limited. Other markers include AST, ALT, and mean corpuscular volume (MCV).
NEW BIOCHEMICAL MARKERS
CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT)
CDT is a glycoprotein altered during heavy alcohol consumption. It has high specificity but requires specialized testing methods.
5-HYDROXYTRYPTOPHOL (5-HTOL)
The ratio of 5-HTOL to 5-HIAA reflects recent alcohol consumption and can be measured in blood or urine.
BETA-HEXOSAMINIDASE (β-HEX)
β-HEX levels increase with heavy alcohol consumption and normalize after abstinence, showing high sensitivity.
ACETALDEHYDE ADDUCTS
Stable protein-acetaldehyde compounds can serve as markers of alcohol intake and remain elevated for weeks after reduced consumption.
Despite advances, no single biomarker offers perfect sensitivity and specificity. However, combining multiple markers may improve diagnostic accuracy.